TADDEI, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 28.067
EU - Europa 10.979
AS - Asia 4.147
AF - Africa 320
OC - Oceania 36
SA - Sud America 27
Continente sconosciuto - Info sul continente non disponibili 10
Totale 43.586
Nazione #
US - Stati Uniti d'America 27.327
IT - Italia 4.365
CN - Cina 2.111
SE - Svezia 1.958
BG - Bulgaria 1.195
DE - Germania 884
CA - Canada 716
SG - Singapore 637
GB - Regno Unito 631
UA - Ucraina 529
TR - Turchia 496
VN - Vietnam 455
FI - Finlandia 424
CH - Svizzera 212
CI - Costa d'Avorio 200
HK - Hong Kong 189
IN - India 160
FR - Francia 141
SM - San Marino 140
RU - Federazione Russa 133
BE - Belgio 92
AT - Austria 89
SN - Senegal 66
ES - Italia 34
CZ - Repubblica Ceca 33
NL - Olanda 28
AU - Australia 26
NG - Nigeria 21
PL - Polonia 20
BR - Brasile 18
MX - Messico 17
JP - Giappone 16
ID - Indonesia 14
IE - Irlanda 12
ZA - Sudafrica 12
HR - Croazia 11
EU - Europa 10
HU - Ungheria 10
KR - Corea 10
NZ - Nuova Zelanda 10
IL - Israele 8
IR - Iran 8
GR - Grecia 6
LU - Lussemburgo 6
TH - Thailandia 6
EG - Egitto 5
MY - Malesia 5
PK - Pakistan 5
PT - Portogallo 5
RO - Romania 5
BJ - Benin 4
GH - Ghana 4
JM - Giamaica 4
SI - Slovenia 4
BN - Brunei Darussalam 3
CL - Cile 3
CY - Cipro 3
KE - Kenya 3
LV - Lettonia 3
NO - Norvegia 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
CO - Colombia 2
DK - Danimarca 2
KZ - Kazakistan 2
LB - Libano 2
MA - Marocco 2
MK - Macedonia 2
NP - Nepal 2
PE - Perù 2
PH - Filippine 2
SC - Seychelles 2
TW - Taiwan 2
UZ - Uzbekistan 2
AL - Albania 1
BD - Bangladesh 1
CR - Costa Rica 1
CU - Cuba 1
DZ - Algeria 1
HN - Honduras 1
KG - Kirghizistan 1
KH - Cambogia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
Totale 43.586
Città #
Woodbridge 4.299
Ann Arbor 3.280
Fairfield 3.055
Houston 2.768
Chandler 1.892
Ashburn 1.444
Sofia 1.192
Seattle 1.169
Serra 1.093
Wilmington 1.041
Cambridge 1.025
Milan 858
Beijing 762
New York 709
Jacksonville 707
Ottawa 679
Boardman 541
Princeton 523
Lawrence 481
Izmir 470
Medford 427
Nanjing 402
Des Moines 307
Singapore 261
Dearborn 201
Abidjan 200
Dong Ket 196
Lancaster 196
Nanchang 186
Bern 182
Florence 180
Hong Kong 167
Pisa 167
Rome 160
San Diego 156
Boulder 130
Falls Church 115
Frankfurt am Main 110
Kunming 110
Jüchen 109
London 102
Ogden 90
Vienna 87
Redwood City 81
Brussels 79
Shenyang 79
Dakar 66
Norwalk 64
Hebei 62
Changsha 61
Pune 59
Tianjin 55
Los Angeles 53
Hefei 50
Jiaxing 49
Washington 45
Auburn Hills 33
Dallas 33
Jinan 31
Hangzhou 30
Nürnberg 29
Padova 29
Orange 27
Marseille 25
Naples 25
Detroit 24
Bremen 23
Changchun 23
Phoenix 23
Guangzhou 20
Lagos 20
Turin 20
Bologna 19
Fremont 18
Grafing 18
Lanzhou 18
Palermo 18
Warsaw 18
Chengdu 17
Livorno 17
Verona 17
Catania 15
Indiana 15
Parma 15
San Francisco 15
Stockholm 14
Zhengzhou 14
Chicago 13
Paris 13
Council Bluffs 12
Bari 11
Genoa 11
Hyderabad 11
Kent 11
Napoli 11
Shanghai 11
Brno 10
Central District 10
Edinburgh 10
Fuzhou 10
Totale 33.839
Nome #
Calcolo dell’Età Vascolare: un nuovo e concreto target terapeutico 1.201
Randomized trial on the effects of a combined physical/cognitive training in aged MCI subjects: the Train the Brain study 244
Prognostic Value Of 24-hour Ambulatory Blood Pressure And Heart Rate Patterns In Diabetes: A 20-year Longitudinal Analysis Of The Chronic Diabetes Complications And All-cause Mortality In Pisa From 1999 Onwards (CHAMP1ON) Study Cohort 224
Renal vasodilating capacity and endothelial function are impaired in patients with obstructive sleep apnea syndrome and no traditional cardiovascular risk factors 183
Dynamic evaluation of renal resistive index in normoalbuminuric patients with newly diagnosed hypertension or type 2 diabetes 178
Vascular Function Is Improved After an Environmental Enrichment Program: The Train the Brain-Mind the Vessel Study 175
INCREASED CENTRAL PRESSURE AUGMENTATION IS ASSOCIATED WITH REDUCED SLEEP DURATION IN INDIVIDUALS EXPOSED TO AIRCRAFT NOISE POLLUTION: THE SERA-CV STUDY 166
Association Between Blood Pressure Variability, Cardiovascular Disease And Mortality In Type 2 Diabetes: A Systematic Review And Meta-Analysis 165
Cigarette Smoking and Hypertension 164
Maximal postischemic forearm vasodilation in human hypertension: a reassessment of the method 161
Type 2 diabetes mellitus worsens arterial stiffness in hypertensive patients through endothelial dysfunction. 161
Endothelial Function and Renal Vasodilation, But not Arterial Stiffness, are Impaired in Lean, Normotensive Patients with Sleep-Apnea Syndrome 158
Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study 156
Angiotensin receptor blockers: Therapeutic targets and cardiovascular protection 150
Recombinant human TSH reduces endothelium-dependent vasodilation in patients monitored for differentiated thyroid carcinoma 150
ROLE OF ENDOTHELIAL NO IN THE VASORELAXING EFFECTS INDUCED BY H2S IN CONDUCTANCE AND RESISTANCE RAT ARTERIES 150
Functional and structural alterations of large arteries: methodological issues. 149
null 149
Effect of verapamil, trandolapril and their combination on vascular function and structure in essential hypertensive patients. 148
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition 147
Combination therapy with lercanidipine and enalapril reduced central blood pressure augmentation in hypertensive patients with metabolic syndrome 146
“Cardiovascular parameters changes in patients with erectile dysfunction using 5-PDE inhibitors: a first study with Sildenafil 50 mg and Vardenafil 10 mg.” 145
Adipocytokine levels mark endothelial function in normotensive individuals 145
Birth weight and arterial hypertension 145
Anthropometric and dietary determinants of blood pressure in over 7000 Mediterranean women: the European Prospective Investigation into Cancer and Nutrition-Florence cohort 144
Vascular renin-angiotensin system and neurotransmission in hypertensive persons. 144
Potassium-rich and sodium-poor salt reduces blood pressure in hospitalized patients. 140
Cholecalciferol administration blunts the systemic renin-angiotensin system in essential hypertensives with hypovitaminosis D. 140
Phosphodiesterase 5 inhibition to treat essential hypertension: is this the beginning of the story? 139
Adenosine causes the release of active renin and angiotensin II in the coronary circulation of patients with essential hypertension 139
Active and inactive renin in human forearm of hypertensive patients. 138
At the beginning of stiffening: endothelial dysfunction meets "pulsology" 138
Oxidative stress, chronic inflammation, and telomere length in patients with periodontitis 138
Obesity in the childhood: a link to adult hypertension 138
Pathogenetic factors in hypertension. Endothelial factors. 137
Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women 137
The effects of diuretic and beta-blocker treatment on cardiac and vascular structural changes in untreated essential hypertensive patients. 136
null 136
Adenosine causes angiotensin II release in human forearm arterioles. 136
Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation 135
null 134
Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension 134
Acute pressure overload induces oxidative stress and tPA expression in rat mesenteric small arteries 133
Endothelial dysfunction in hypertension: Pathophysiological mechanism or marker of cardiovascular risk? 133
Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers 132
Menopause is associated with endothelial dysfunction in women 131
Endothelium-dependent contractions to endothelin in the rat aorta are mediated by thromboxane A2. 130
Renal changes induced by nitric oxide and prostaglandin synthesis reduction: effects of trandolapril and verapamil. 130
Device-based therapies for resistant hypertension. 130
Multiparametric evaluation of vascular function in lean, normotensive patients with obstructive sleep apnoea 129
Endothelium-dependent vasodilation in hypertensive patients 126
Hypertension in special populations: athletes. 126
Interactions between sympathetic nervous system and endogenous endothelin in patients with essential hypertension. 125
Adenosine activates a vascular renin-angiotensin system in hypertensive subjects. 125
Identification of a cytochrome P450-2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients 125
Hypertension causes premature aging of endothelial function in humans 125
Adenosine and the vascular tissue renin-angiotensin system in the forearm of essential hypertensive patients 124
Different Impact of Essential Hypertension on Structural and Functional Age-Related Vascular Changes 124
A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke 123
Blood pressure through aging and menopause 123
Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes. 123
The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients 123
Efficacy and Safety of Olmesartan Medoxomil 40 mg/Hydrochlorothiazide 12.5 mg Combination Therapy versus Olmesartan Medoxomil 40 mg Monotherapy in Patients with Moderate to Severe Hypertension 122
Early impairment of coronary flow reserve and increase in minimum coronary resistance in borderline hypertensive patients 122
Dapagliflozin acutely improves endothelial dysfunction, reduces aortic stiffness and renal resistive index in type 2 diabetic patients: A pilot study 122
Calcium entry blockade and selective alpha-adrenergic stimulation in animals and humans 121
Angiotensin II and sympathetic activity in sodium-restricted essential hypertension. 121
Inhibitors of angiotensin-converting enzyme in the treatment of arterial hypertension. 120
Evolving the concept of regulation of vascular tone in humans. 120
The assessment of endothelial function: from research into clinical practice. 120
Angiotensin-converting enzyme inhibitors in hypertension: a review. Int 119
Chronic Treatment With Long-Acting Nifedipine Reduces Vasoconstriction to Endothelin-1 in Essential Hypertension. Hypertension 119
Third molar surgical removal: a possible model of human systemic inflammation? A preliminary investigation 119
VASORELAXING EFFECTS OF H2S IN RAT MESENTERIC ARTERIES 119
Endothelial dysfunction in hypertension. 118
Prognostic value of flow mediated dilation in patients with systemic lupus erythematosus: A pilot prospective cohort study. 118
Vascular tissue renin-angiotensin system in hypertensive humans. 117
Endothelial progenitor cells and endothelial dysfunction in prediabetic and newly diagnosed type 2 diabetic subjects 117
Sporadic or familial head neck paragangliomas enrolled in a single center: Clinical presentation and genotype/phenotype correlations 117
Early impairment of coronary flow reserve and increase in minimum coronary resistance in borderline hypertensive patients 117
Insulin sensitivity, vascular reactivity, and clamp-induced vasodilatation in essential hypertension 117
Effect of acute administration of vitamin C on muscle sympathetic activity, cardiac sympathovagal balance, and baroreflex sensitivity in hypertensive patients. 116
Lack of evidence for Na/K ATPase inhibitor as a cause of low renin human hypertension. 115
Rationale and design of dal-VESSEL: a study to assess the safety and efficacy of dalcetrapib on endothelial function using brachial artery flow-mediated vasodilatation. 115
Microvascular endothelial dysfunction in obesity and hypertension. 115
Vascular dysfunction in a mouse model of rett syndrome and effects of curcumin treatment. 115
Response to Endothelial nitric oxide synthase, cyclooxygenase-2, and essential hypertension: is there an interaction? 115
1140-1147 Association between short leukocyte telomere length, endotoxemia, and severe periodontitis in people with diabetes: A cross-sectional survey 115
Oxidative Stress and Vascular Damage in Hypertension: Role of Angiotensin II 114
Cholecalciferol treatment downregulates renin-angiotensin systemand improves endothelial function in essential hypertensive patients with hypovitaminosid D 114
Microalbuminuria and renal haemodynamics in essential hypertension. 113
Aging and endothelial function. 113
Cutaneous vasodilation to acetylcholine in patients with essential hypertension 113
Effect of calcium antagonist or beta blockade treatment on nitric oxide-dependent vasodilation and oxidative stress in essential hypertensive patients. 113
Antihypertensive drugs and reversing of endothelial dysfunction in hypertension 113
Ventricular and vascular stiffening in aging and hypertension 113
null 112
Dipyridamole decreases circulating renin-angiotensin system activity in hypertensive patients. 112
Vascular renin-angiotensin system and sympathetic nervous system activity in human hypertension. 112
Independent stimulation of glucose metabolism and Na+-K+ exchange by insulin in the human forearm. 112
Totale 14.408
Categoria #
all - tutte 119.955
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.955


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.759 0 0 1.006 530 782 835 959 632 769 484 619 143
2020/20213.422 292 177 222 161 364 147 275 352 334 307 210 581
2021/20225.453 138 334 106 380 1.026 723 162 324 258 202 320 1.480
2022/20236.005 774 671 359 518 610 819 84 463 1.055 79 430 143
2023/20244.865 545 491 567 359 691 830 187 188 141 111 204 551
2024/2025798 166 632 0 0 0 0 0 0 0 0 0 0
Totale 44.261